Added to YB: 2019-01-14
Pitch date: 2019-01-14
CELG:US [bullish]
Celgene Corporation
+24.21%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide.
Market Cap
$77.0B
Pitch Price
$87.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
13.31
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
CELGENE CORP CELG:US
A summary for this pitch has not been created yet.
Read full article (0 min)